Skip to main navigation Skip to search Skip to main content

Non-invasive fetal sexing: medical test or a new tool for sex selection?

    • University of Warwick

    Research output: Contribution to journalArticlepeer-review

    167 Downloads (Pure)

    Abstract

    Recent scientific developments in prenatal testing, based on fetal DNA in maternal blood, now allow non-invasive fetal sexing in pregnancies at risk of a sex-linked disorder. In such cases, these novel noninvasive tests can improve prenatal care by avoiding the need for invasive procedures such as amniocentesis, with their associated risk of fetal loss. The tests available for medical use are characterized by high levels of accuracy (> 99%) and early fetal sex determination (from week 7 of gestation). Many countries now offer families at risk of a sex-linked disorder this new form of clinical fetal sexing. At the same time, further developments in fetal DNA technology are making antenatal sex determination possible via a finger prick sample mailed anonymously to a commercial organization. Direct marketing to future parents of such non-invasive tests for social sex determination will bypass a woman’s physician. This could allow termination based on sex selection while women ostensibly present to physicians, who will have no access to the test result, for a termination on social grounds. If test results are available at 7 weeks gestation, online purchase of products for non-surgical abortion at home early in pregnancy could also enable some parents to bypass a health system altogether. Female feticide, linked to son preference and widespread ultrasound diffusion, has already led to significant gender imbalances in India and China. Certain ethnic minority communities in the west are also now displaying evidence of fetal sex selection. Currently, mail-order fetal sexing, based on fetal DNA in maternal blood, is still an emerging market. However, before any widespread diffusion, discussion about the implications of this new technology and associated issues is important and timely. This article considers evidence of technology development, existing demographic and social changes, corporate responsibility in product marketing, and the role of community engagement and education.
    Original languageEnglish
    Pages (from-to)37-44
    Number of pages8
    JournalDiversity & Equality in Health and Care
    Volume8
    Issue number1
    Publication statusPublished - 12 Oct 2010

    Bibliographical note

    Full text available from: http://diversityhealthcare.imedpub.com/noninvasive-fetal-sexing-medical-test-or-a-new-tool-for-sex-selection.php?aid=1911

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • fetal sex determination
    • gender imbalance
    • non-invasive diagnosis
    • prenatal testing
    • sex selection
    • son preference

    Fingerprint

    Dive into the research topics of 'Non-invasive fetal sexing: medical test or a new tool for sex selection?'. Together they form a unique fingerprint.

    Cite this